"Cooper and Waldby have done an admirable job of highlighting at least two key aspects of the bioeconomy that are in need of more theoretical and, especially, empirical work; these are the importance of contracts and assets." — Kean Birch, New Genetics and Society
“In the literature on contributors to medical knowledge, attention is most often focused on basic and applied researchers, funders, and regulators. In Clinical Labor, Cooper and Waldby focus on an essential, overlooked, and perhaps exploited population, that of research subjects. The authors are at their strongest in applying a Marxist theoretical perspective to class in medical research and the need to conceptualize participation in clinical trials as labor. . . . Recommended. Graduate students, researchers/faculty, and professionals/practitioners.” — M. D. Lagerwey, Choice
"It reveals the brute commercial nature of some of the bodily exchanges on which biomedical innovation increasingly relies." — Erik Malmqvist, Medicine, Health Care and Philosophy
"Poised to be not only a classic analysis of the bioeconomy, but the strongest exemplar of a style of analysis of which we urgently need more." — Aaron Panofsky, Social Forces
"Melinda Cooper and Catherine Waldby's Clinical Labor: Tissue Donors and Research Subjects in the Global Bioeconomy offers a highly original, gendered analysis of expansive and emergent labor forms "hidden in plain sight" in the rapidly proliferating bioeconomy.... Clinical Labor provides a forceful instance of Marxist–feminist theory, focusing on the next stage of capital accumulation, worker consciousness, and potential opposition." — Rayna Rapp, Bulletin of the History of Medicine
"In scholarship on the contemporary role and practices of the biosciences in the production of knowledge, value, and life itself,Clinical Labor stands out as an important contribution that helps make sense of new incorporations of bodies, stratifications, and relation.... Clinical Labor is sweeping and comprehensive, fluidly showing how legal concepts and economic practices interweave with biomedical production and bioethics." — Janet K. Shim, American Journal of Sociology
"Overall, Clinical Labor is a compelling and thought-provoking book. It provides an excellent overview of political bioeconomy and brings up a broad range of intriguing questions for readers interested in biomedical economies or Marxist thought." — Heather Edelblute, ISIS
"Cooper and Waldby expertly offer a comprehensive and substantial argument for why a reconceptualization of human subject experimentation as clinical labor is necessary by outlining inadequacies and challenges within existing regulation. This book is a provocative read suitable for scholars in multiple fields of the social sciences." — Por Heong Hong, East Asian Science, Technology and Society
"Clinical Labor is a welcome contribution to social studies of biomedicine. The book should concern everyone interested in the articulation of life, value and labor in global (bio-)economies.... Critical studies of biomedicine would benefit from further engaging with Clinical Labor, both empirically and conceptually.” — Christian Haddad, Life Sciences, Society and Policy
"At last! A paradigm-shifting theorizing of 'biolabor'—largely invisible, underpaid, or donated work that produces invaluable human materials for highly lucrative pharmaceutical and assisted reproductive technology industries. Melinda Cooper and Catherine Waldby brilliantly analyze such labor as continuous with low-waged distributed piecework characteristic of twenty-first-century post-Fordist bioeconomies, including venture labor (high risk/no pay). These highly gendered and racialized divisions of labor are eerily bioethics-approved as they outsource risk to individual worker 'entrepreneurs' and put 'life itself' to work for biocapital. Brava!" — Adele E. Clarke, coeditor of Biomedicalization: Technoscience, Health, and Illness in the U.S.